These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26215834)

  • 21. PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.
    Xu HM; Tan L; Wan Y; Tan MS; Zhang W; Zheng ZJ; Kong LL; Wang ZX; Jiang T; Tan L; Yu JT
    Mol Neurobiol; 2017 Mar; 54(2):1187-1195. PubMed ID: 26820675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.
    Piscopo P; Rivabene R; Galimberti D; Crestini A; Talarico G; Vanacore N; Scarpini E; Bruno G; Confaloni A
    J Alzheimers Dis; 2013; 35(2):313-8. PubMed ID: 23396349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation modulates the association of PGRN with cerebral amyloid-β burden.
    Xu W; Tan CC; Cao XP; Tan L;
    Neurobiol Aging; 2021 Jul; 103():52-59. PubMed ID: 33813350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
    Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progranulin protects against renal ischemia/reperfusion injury in mice.
    Zhou M; Tang W; Fu Y; Xu X; Wang Z; Lu Y; Liu F; Yang X; Wei X; Zhang Y; Liu J; Geng X; Zhang C; Wan Q; Li N; Yi F
    Kidney Int; 2015 May; 87(5):918-29. PubMed ID: 25607110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.
    de la Encarnación A; Alquézar C; Martín-Requero Á
    Mol Neurobiol; 2016 Dec; 53(10):7107-7118. PubMed ID: 26676574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
    Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
    Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Progranulin and Gaucher Disease.
    Jian J; Zhao S; Tian QY; Liu H; Zhao Y; Chen WC; Grunig G; Torres PA; Wang BC; Zeng B; Pastores G; Tang W; Sun Y; Grabowski GA; Kong MX; Wang G; Chen Y; Liang F; Overkleeft HS; Saunders-Pullman R; Chan GL; Liu CJ
    EBioMedicine; 2016 Sep; 11():127-137. PubMed ID: 27515686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Mao Q; Wang D; Li Y; Kohler M; Wilson J; Parton Z; Shmaltsuyeva B; Gursel D; Rademakers R; Weintraub S; Mesulam MM; Xia H; Bigio EH
    J Neuropathol Exp Neurol; 2017 Nov; 76(11):957-968. PubMed ID: 29044416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progranulin promotes activation of microglia/macrophage after pilocarpine-induced status epilepticus.
    Zhu S; Tai C; Petkau TL; Zhang S; Liao C; Dong Z; Wen W; Chang Q; Tian Wang Y; MacVicar BA; Leavitt BR; Jia W; Cynader MS
    Brain Res; 2013 Sep; 1530():54-65. PubMed ID: 23887054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Brouwers N; Nuytemans K; van der Zee J; Gijselinck I; Engelborghs S; Theuns J; Kumar-Singh S; Pickut BA; Pals P; Dermaut B; Bogaerts V; De Pooter T; Serneels S; Van den Broeck M; Cuijt I; Mattheijssens M; Peeters K; Sciot R; Martin JJ; Cras P; Santens P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; Sleegers K
    Arch Neurol; 2007 Oct; 64(10):1436-46. PubMed ID: 17923627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.